Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3008949018 | Dapagliflozin | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3009007019 | Dapagliflozin (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3488346019 | Product containing dapagliflozin (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3497244017 | Product containing dapagliflozin | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3669093010 | Dapagliflozin product | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3714264015 | Dapagliflozin-containing product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 107878901000001119 | Dapagliflozin | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing dapagliflozin | Is a | Product containing sodium glucose cotransporter subtype 2 inhibitor | true | Inferred relationship | Existential restriction modifier | ||
| Product containing dapagliflozin | Has active ingredient | Dapagliflozin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing dapagliflozin | Is a | Virtual therapeutic moiety | false | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets